nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—Crohn's disease	0.0651	0.889	CrCbGaD
Nalbuphine—OPRD1—Peptide GPCRs—CCR9—Crohn's disease	0.0205	0.028	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide GPCRs—CCR9—Crohn's disease	0.0179	0.0246	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide GPCRs—CCR9—Crohn's disease	0.0152	0.0208	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0146	0.0201	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0139	0.019	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide GPCRs—CCR6—Crohn's disease	0.0136	0.0186	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0128	0.0176	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0122	0.0167	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide GPCRs—CCR6—Crohn's disease	0.0119	0.0163	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0115	0.0157	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0109	0.0149	CbGpPWpGaD
Nalbuphine—Micturition urgency—Mesalazine—Crohn's disease	0.0105	0.0531	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0103	0.0141	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0101	0.0138	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.01	0.0138	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00982	0.0135	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00962	0.0132	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00931	0.0128	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00861	0.0118	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0085	0.0116	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00844	0.0116	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00816	0.0112	CbGpPWpGaD
Nalbuphine—Naloxone—ALB—Crohn's disease	0.00812	0.111	CrCbGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00812	0.0111	CbGpPWpGaD
Nalbuphine—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.0076	0.0104	CbGpPWpGaD
Nalbuphine—Feeling hot—Mesalazine—Crohn's disease	0.00757	0.0384	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00753	0.0103	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00748	0.0102	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.00745	0.0102	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00728	0.00998	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00713	0.00977	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00712	0.00975	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.00709	0.00972	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.007	0.0096	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0069	0.00946	CbGpPWpGaD
Nalbuphine—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.00682	0.00935	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00661	0.00905	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.0066	0.00905	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00656	0.00899	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00645	0.00884	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00637	0.00873	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.00622	0.00852	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00614	0.00842	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00602	0.00824	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.006	0.00822	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00566	0.00776	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00559	0.00766	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00558	0.00765	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.00554	0.0076	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00538	0.00737	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00526	0.00721	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.00525	0.0072	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00519	0.00711	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00499	0.00684	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.00491	0.00674	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00478	0.00655	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00472	0.00647	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00471	0.00646	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.00457	0.00626	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00445	0.00609	CbGpPWpGaD
Nalbuphine—Delusion—Prednisone—Crohn's disease	0.00444	0.0225	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00439	0.00602	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00438	0.006	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.00431	0.00591	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00428	0.00586	CbGpPWpGaD
Nalbuphine—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.00409	0.0056	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.00401	0.00549	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.00401	0.00549	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00398	0.00546	CbGpPWpGaD
Nalbuphine—Oedema—Mercaptopurine—Crohn's disease	0.0039	0.0198	CcSEcCtD
Nalbuphine—Cramp muscle—Mesalazine—Crohn's disease	0.00388	0.0197	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00385	0.00528	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.00384	0.00526	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00376	0.00516	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00375	0.00514	CbGpPWpGaD
Nalbuphine—Asthma—Mesalazine—Crohn's disease	0.00373	0.0189	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.0037	0.00507	CbGpPWpGaD
Nalbuphine—Bronchospasm—Mesalazine—Crohn's disease	0.00366	0.0186	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00364	0.00499	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.00364	0.00499	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.00351	0.00482	CbGpPWpGaD
Nalbuphine—Pollakiuria—Mesalazine—Crohn's disease	0.00344	0.0175	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00339	0.00464	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.00337	0.00461	CbGpPWpGaD
Nalbuphine—Depression—Mesalazine—Crohn's disease	0.00331	0.0168	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0033	0.00452	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00326	0.00446	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.00326	0.00446	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.00319	0.00437	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00317	0.00434	CbGpPWpGaD
Nalbuphine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00309	0.0157	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.00297	0.00407	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00288	0.0146	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.00287	0.00394	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.00287	0.00393	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.00285	0.00391	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00284	0.0039	CbGpPWpGaD
Nalbuphine—Pulmonary oedema—Prednisone—Crohn's disease	0.0028	0.0142	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00279	0.00382	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.00278	0.00381	CbGpPWpGaD
Nalbuphine—Euphoric mood—Prednisone—Crohn's disease	0.0027	0.0137	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.0027	0.0037	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00265	0.00364	CbGpPWpGaD
Nalbuphine—Erythema—Mesalazine—Crohn's disease	0.0026	0.0132	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.00258	0.00354	CbGpPWpGaD
Nalbuphine—Tension—Mesalazine—Crohn's disease	0.00255	0.0129	CcSEcCtD
Nalbuphine—Dysgeusia—Mesalazine—Crohn's disease	0.00254	0.0129	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.00252	0.00346	CbGpPWpGaD
Nalbuphine—Nervousness—Mesalazine—Crohn's disease	0.00252	0.0128	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.00251	0.00344	CbGpPWpGaD
Nalbuphine—Muscle spasms—Mesalazine—Crohn's disease	0.0025	0.0127	CcSEcCtD
Nalbuphine—Vomiting—Mercaptopurine—Crohn's disease	0.00248	0.0126	CcSEcCtD
Nalbuphine—Rash—Mercaptopurine—Crohn's disease	0.00246	0.0125	CcSEcCtD
Nalbuphine—Dermatitis—Mercaptopurine—Crohn's disease	0.00246	0.0125	CcSEcCtD
Nalbuphine—Vision blurred—Mesalazine—Crohn's disease	0.00245	0.0124	CcSEcCtD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.00244	0.00334	CbGpPWpGaD
Nalbuphine—Tremor—Mesalazine—Crohn's disease	0.00243	0.0123	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00241	0.00331	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.00234	0.00321	CbGpPWpGaD
Nalbuphine—Vertigo—Mesalazine—Crohn's disease	0.00233	0.0118	CcSEcCtD
Nalbuphine—Syncope—Mesalazine—Crohn's disease	0.00233	0.0118	CcSEcCtD
Nalbuphine—Nausea—Mercaptopurine—Crohn's disease	0.00232	0.0118	CcSEcCtD
Nalbuphine—Loss of consciousness—Mesalazine—Crohn's disease	0.00228	0.0116	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.00227	0.00311	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.00226	0.0031	CbGpPWpGaD
Nalbuphine—Hypertension—Mesalazine—Crohn's disease	0.00224	0.0114	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.00221	0.00303	CbGpPWpGaD
Nalbuphine—Anxiety—Mesalazine—Crohn's disease	0.0022	0.0112	CcSEcCtD
Nalbuphine—Hypotension—Azathioprine—Crohn's disease	0.00217	0.011	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisone—Crohn's disease	0.00217	0.011	CcSEcCtD
Nalbuphine—Dry mouth—Mesalazine—Crohn's disease	0.00216	0.011	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.00215	0.00295	CbGpPWpGaD
Nalbuphine—Confusional state—Mesalazine—Crohn's disease	0.00214	0.0108	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00212	0.00291	CbGpPWpGaD
Nalbuphine—Oedema—Mesalazine—Crohn's disease	0.00212	0.0107	CcSEcCtD
Nalbuphine—Shock—Mesalazine—Crohn's disease	0.00208	0.0106	CcSEcCtD
Nalbuphine—Tachycardia—Mesalazine—Crohn's disease	0.00207	0.0105	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00206	0.00282	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.00206	0.00282	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00205	0.00281	CbGpPWpGaD
Nalbuphine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00205	0.0104	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.00199	0.00272	CbGpPWpGaD
Nalbuphine—Hypotension—Mesalazine—Crohn's disease	0.00198	0.01	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.00197	0.00269	CbGpPWpGaD
Nalbuphine—Sweating increased—Prednisone—Crohn's disease	0.00192	0.00974	CcSEcCtD
Nalbuphine—Feeling abnormal—Azathioprine—Crohn's disease	0.00192	0.00972	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00191	0.00262	CbGpPWpGaD
Nalbuphine—Paraesthesia—Mesalazine—Crohn's disease	0.0019	0.00965	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.0019	0.00965	CcSEcCtD
Nalbuphine—Dyspnoea—Mesalazine—Crohn's disease	0.00189	0.00958	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.00188	0.00258	CbGpPWpGaD
Nalbuphine—Somnolence—Mesalazine—Crohn's disease	0.00188	0.00956	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00187	0.00256	CbGpPWpGaD
Nalbuphine—Dyspepsia—Mesalazine—Crohn's disease	0.00186	0.00946	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.00184	0.00252	CbGpPWpGaD
Nalbuphine—Body temperature increased—Azathioprine—Crohn's disease	0.00184	0.00933	CcSEcCtD
Nalbuphine—Abdominal pain—Azathioprine—Crohn's disease	0.00184	0.00933	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.0018	0.00247	CbGpPWpGaD
Nalbuphine—Depression—Prednisone—Crohn's disease	0.00175	0.00889	CcSEcCtD
Nalbuphine—Feeling abnormal—Mesalazine—Crohn's disease	0.00175	0.00886	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00174	0.00238	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00173	0.00237	CbGpPWpGaD
Nalbuphine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00173	0.00879	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.00172	0.00236	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00172	0.00235	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Azathioprine—Crohn's disease	0.00171	0.00869	CcSEcCtD
Nalbuphine—Urticaria—Mesalazine—Crohn's disease	0.00168	0.00854	CcSEcCtD
Nalbuphine—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.00168	0.0023	CbGpPWpGaD
Nalbuphine—Body temperature increased—Mesalazine—Crohn's disease	0.00167	0.0085	CcSEcCtD
Nalbuphine—Abdominal pain—Mesalazine—Crohn's disease	0.00167	0.0085	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.00167	0.00229	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.00163	0.00223	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00162	0.00222	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.00161	0.00221	CbGpPWpGaD
Nalbuphine—Bradycardia—Prednisone—Crohn's disease	0.00161	0.00815	CcSEcCtD
Nalbuphine—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.00159	0.00218	CbGpPWpGaD
Nalbuphine—Hallucination—Prednisone—Crohn's disease	0.00157	0.00796	CcSEcCtD
Nalbuphine—Hypersensitivity—Mesalazine—Crohn's disease	0.00156	0.00792	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.00155	0.00213	CbGpPWpGaD
Nalbuphine—Dizziness—Azathioprine—Crohn's disease	0.00154	0.0078	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00152	0.00209	CbGpPWpGaD
Nalbuphine—Asthenia—Mesalazine—Crohn's disease	0.00152	0.00771	CcSEcCtD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00152	0.00208	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.00151	0.00206	CbGpPWpGaD
Nalbuphine—Pruritus—Mesalazine—Crohn's disease	0.0015	0.0076	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.00149	0.00204	CbGpPWpGaD
Nalbuphine—Vomiting—Azathioprine—Crohn's disease	0.00148	0.0075	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.00147	0.00202	CbGpPWpGaD
Nalbuphine—Rash—Azathioprine—Crohn's disease	0.00147	0.00744	CcSEcCtD
Nalbuphine—Dermatitis—Azathioprine—Crohn's disease	0.00147	0.00743	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.00147	0.00201	CbGpPWpGaD
Nalbuphine—Flushing—Prednisone—Crohn's disease	0.00146	0.00743	CcSEcCtD
Nalbuphine—Headache—Azathioprine—Crohn's disease	0.00146	0.00739	CcSEcCtD
Nalbuphine—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.00146	0.002	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.00143	0.00196	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00142	0.00195	CbGpPWpGaD
Nalbuphine—Dizziness—Mesalazine—Crohn's disease	0.0014	0.00711	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.00139	0.0019	CbGpPWpGaD
Nalbuphine—Nausea—Azathioprine—Crohn's disease	0.00138	0.00701	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.00138	0.00189	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00138	0.00189	CbGpPWpGaD
Nalbuphine—Erythema—Prednisone—Crohn's disease	0.00137	0.00697	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.00136	0.00187	CbGpPWpGaD
Nalbuphine—Vomiting—Mesalazine—Crohn's disease	0.00135	0.00683	CcSEcCtD
Nalbuphine—Rash—Mesalazine—Crohn's disease	0.00134	0.00678	CcSEcCtD
Nalbuphine—Dermatitis—Mesalazine—Crohn's disease	0.00133	0.00677	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00133	0.00183	CbGpPWpGaD
Nalbuphine—Headache—Mesalazine—Crohn's disease	0.00133	0.00673	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.00131	0.00179	CbGpPWpGaD
Nalbuphine—Vision blurred—Prednisone—Crohn's disease	0.00129	0.00657	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.00129	0.00177	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00128	0.00176	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00127	0.00175	CbGpPWpGaD
Nalbuphine—Agitation—Prednisone—Crohn's disease	0.00126	0.0064	CcSEcCtD
Nalbuphine—Nausea—Mesalazine—Crohn's disease	0.00126	0.00638	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.00125	0.00172	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.00124	0.0017	CbGpPWpGaD
Nalbuphine—Vertigo—Prednisone—Crohn's disease	0.00123	0.00626	CcSEcCtD
Nalbuphine—Syncope—Prednisone—Crohn's disease	0.00123	0.00625	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.00121	0.00166	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00121	0.00166	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.00121	0.00166	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00121	0.00166	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.00121	0.00165	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Prednisone—Crohn's disease	0.00121	0.00612	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.0012	0.00165	CbGpPWpGaD
Nalbuphine—Convulsion—Prednisone—Crohn's disease	0.00119	0.00604	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—Crohn's disease	0.00119	0.00602	CcSEcCtD
Nalbuphine—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00117	0.0016	CbGpPWpGaD
Nalbuphine—Anxiety—Prednisone—Crohn's disease	0.00117	0.00591	CcSEcCtD
Nalbuphine—Oedema—Prednisone—Crohn's disease	0.00112	0.00569	CcSEcCtD
Nalbuphine—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.0011	0.00151	CbGpPWpGaD
Nalbuphine—Shock—Prednisone—Crohn's disease	0.0011	0.00559	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.0011	0.00151	CbGpPWpGaD
Nalbuphine—Tachycardia—Prednisone—Crohn's disease	0.00109	0.00555	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.00109	0.00149	CbGpPWpGaD
Nalbuphine—Hyperhidrosis—Prednisone—Crohn's disease	0.00108	0.0055	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00106	0.00146	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.00105	0.00144	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.00103	0.00141	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.00102	0.0014	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00102	0.0014	CbGpPWpGaD
Nalbuphine—Paraesthesia—Prednisone—Crohn's disease	0.00101	0.00511	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000989	0.00136	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000987	0.00135	CbGpPWpGaD
Nalbuphine—Dyspepsia—Prednisone—Crohn's disease	0.000987	0.00501	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000966	0.00132	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000928	0.00127	CbGpPWpGaD
Nalbuphine—Feeling abnormal—Prednisone—Crohn's disease	0.000924	0.00469	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.00092	0.00126	CbGpPWpGaD
Nalbuphine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000917	0.00465	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000898	0.00123	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000893	0.00122	CbGpPWpGaD
Nalbuphine—Urticaria—Prednisone—Crohn's disease	0.00089	0.00452	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—Crohn's disease	0.000886	0.0045	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—Crohn's disease	0.000886	0.0045	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000878	0.0012	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000869	0.00119	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000865	0.00119	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000847	0.00116	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Prednisone—Crohn's disease	0.000826	0.00419	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—Crohn's disease	0.000804	0.00408	CcSEcCtD
Nalbuphine—Pruritus—Prednisone—Crohn's disease	0.000793	0.00402	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000783	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000783	0.00107	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000777	0.00107	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.00077	0.00105	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000762	0.00104	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000759	0.00104	CbGpPWpGaD
Nalbuphine—Dizziness—Prednisone—Crohn's disease	0.000741	0.00376	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.00074	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000731	0.001	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000716	0.000982	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000716	0.000981	CbGpPWpGaD
Nalbuphine—Vomiting—Prednisone—Crohn's disease	0.000713	0.00362	CcSEcCtD
Nalbuphine—Rash—Prednisone—Crohn's disease	0.000707	0.00359	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—Crohn's disease	0.000706	0.00358	CcSEcCtD
Nalbuphine—Headache—Prednisone—Crohn's disease	0.000702	0.00356	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000686	0.000941	CbGpPWpGaD
Nalbuphine—Nausea—Prednisone—Crohn's disease	0.000666	0.00338	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000665	0.000912	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000661	0.000906	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.00065	0.000891	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.00065	0.00089	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000649	0.000889	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000649	0.000889	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000644	0.000882	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000628	0.00086	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000618	0.000847	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000593	0.000812	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.00059	0.000808	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.00058	0.000795	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.00057	0.000781	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000569	0.000779	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000562	0.000771	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	0.00056	0.000767	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL3—Crohn's disease	0.000548	0.000752	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	0.000542	0.000743	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000538	0.000738	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000531	0.000727	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	0.00052	0.000712	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000518	0.00071	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	0.000517	0.000709	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	0.000491	0.000673	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000481	0.00066	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000481	0.000659	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	0.000472	0.000647	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000458	0.000628	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	0.000455	0.000623	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000439	0.000602	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000437	0.000599	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000415	0.000569	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000399	0.000547	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000384	0.000527	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TYK2—Crohn's disease	0.000365	0.000501	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAK2—Crohn's disease	0.000348	0.000478	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TYK2—Crohn's disease	0.00032	0.000439	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000318	0.000436	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAK2—Crohn's disease	0.000306	0.000419	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—Crohn's disease	0.000302	0.000414	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	0.000279	0.000382	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TYK2—Crohn's disease	0.000271	0.000371	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—Crohn's disease	0.000265	0.000363	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAK2—Crohn's disease	0.000258	0.000354	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—Crohn's disease	0.000256	0.000351	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	0.000236	0.000323	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—Crohn's disease	0.000224	0.000307	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—Crohn's disease	0.000224	0.000307	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—Crohn's disease	0.00019	0.00026	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—Crohn's disease	0.000179	0.000245	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—Crohn's disease	0.000157	0.000215	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—Crohn's disease	0.000132	0.000181	CbGpPWpGaD
